Navigation Links
Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine
Date:11/13/2007

CAMBRIDGE, England and CAMBRIDGE, Massachusetts, November 13 /PRNewswire-FirstCall/ --

- No Human Vaccine Currently Exists Against the West Nile Virus, Which has Caused 3,265 Cases and 92 Deaths in the US so far in 2007; Collaboration Aims to Bring Leading West Nile Virus Vaccine Candidate to Market as Rapidly as Possible

Acambis plc (Acambis) (LSE: ACM), a leading vaccine development company, announced today that it has signed an exclusive global collaboration agreement with Sanofi Pasteur, the vaccines division of sanofi-aventis Group, for the development and marketing of Acambis' ChimeriVax(TM)-West Nile vaccine, which is the leading West Nile vaccine in development.

"Since 1999 when it was first detected in the US, the West Nile virus has spread across the entire continental United States, causing 27,240 cases and 1,054 deaths," commented Ian Garland, Chief Executive Officer of Acambis. "Vaccination is the ideal approach to tackling this disease and, through this unique collaboration, we aim to bring this vaccine to market as rapidly as possible."

"Providing a vaccine against West Nile disease may now be within reach. This vaccine candidate is the most promising in the industry and would help meet a growing public health need," said Wayne Pisano, President and Chief Executive Officer of Sanofi Pasteur.

Acambis started developing a West Nile vaccine in 1999, shortly after the virus was first identified in the US. Under the terms of the agreement, Acambis will continue to perform ChimeriVax(TM)-West Nile development activities, up to and including the filing of a license application in the US.

Acambis will receive an upfront payment of $10m in 2007 from Sanofi Pasteur, and would be eligible for pre- and post-marketing milestone payments of up to $70m based on product approval and sales in the US market. It would also be entitled to receive development funding and royalties on net sales of the vaccine. In addition, if the
'/>"/>

SOURCE Acambis plc
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Richard Greco Joins Mediware Board
2. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
3. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
4. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
5. Nick Childs Joins Grey New York as Director of Content Development
6. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
7. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
8. NASN Joins Partnership to Fight Chronic Disease
9. AstraZeneca Joins Local Walking Movement
10. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
11. Fund Manager Joins Board of GSI Securitization Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... new neurons in the hippocampus - a brain region ... could cause forgetting of old memories by causing a ... and Sheena Josselyn, both from the Hospital for Sick ... positive effect of clearing old memories, reducing interference and ... were presented at the 2013 Canadian Neuroscience Meeting, the ...
(Date:5/24/2013)... New York, NY (PRWEB) May 24, 2013 ... has granted Cellular Dynamics International (CDI) exclusive license rights ... cell therapy and regenerative medicine applications. These cells are ... of the heart, including cardiomyocytes, endothelial cells, and vascular ... a potential therapeutic for damaged heart tissue. , The ...
(Date:5/24/2013)... On May 16, students, family members, and ... American University of Antigua (AUA) College of Medicine ... was the largest graduating class to date. The ceremony ... Vice President for Enrollment Management and Chief Operating Officer, ... Dean of Students and Professor and Chair – Physiology, ...
(Date:5/24/2013)... 2013 The creative flair and design ... University (PolyU)'s Institute of Textiles and Clothing (ITC) have ... Fashion Show held on 22 May at The Mira ... of ITC design students, various knitwear producers and yarn ... collections of four outfits from 20 graduating students majoring ...
(Date:5/24/2013)... THURSDAY, May 23 (HealthDay News) -- Type 2 diabetes ... of serious complications seen just a few years after ... latest results, it seems like type 2 is progressing ... vice president of medical affairs and community information for ... it appears to be at a more significant rate ...
Breaking Medicine News(10 mins):Health News:New neuron formation could increase capacity for new learning, at the expense of old memories 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4Health News:AUA Celebrates Seventh Annual Commencement Ceremony 2Health News:PolyU Stages Knitwear Fashion Show 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 3
... Tragedy: The mass shooting in Tucson that ... Congresswoman Gabrielle Giffords, brought significant attention to ... mental, emotional and behavioral disorders (MEBs) and substance abuse. ... be answered by a panel of experts, including Ron ...
... promising cancer treatment drug can restore function of a heart ... UT Southwestern Medical Center have found. The drug, a ... ongoing clinical trials, has been shown to reverse the harmful ... is a natural process by which cells eat their own ...
... enzyme associated with extensive antibiotic resistance called New Delhi ... worldwide, has been found in two people in the ... states a case report in CMAJ ( ... http://www.cmaj.ca/embargo/cmaj110477.pdf . The report outlines challenges and approaches to ...
... May 29 (HealthDay News) -- Attacks by North American black ... rising as the human population of the United States and ... in the Journal of Wildlife Management , also dispels ... mothers with cubs to protect. Researchers reveal that lone male ...
... -- Native American children in the United States and Canada ... other kids, according to a new policy statement from a ... oral health of those patients. A survey of 2,633 ... the United States, Alaska and Canada found that 68 percent ...
... symptoms is distressing for both patient and doctor and ... five patients have symptoms that remain unexplained by conventional ... NHS of managing the treatment of a patient with ... patient with a diagnosis. A research team ...
Cached Medicine News:Health News:Tucson tragedy; college athletes and drinking; depression in adolescents; and yoga and drug use 2Health News:Drug can reverse overgrown hearts to help prevent heart failure, UT Southwestern researchers find 2Health News:New Delhi metallo-beta-lactamase-1 enzyme acquired in Canada 2Health News:Fatal Black Bear Attacks Rare But Rising 2Health News:Native American Children Have More Tooth Decay 2Health News:Acupuncture of benefit to those with unexplained symptoms 2Health News:Acupuncture of benefit to those with unexplained symptoms 3
(Date:5/24/2013)... -- An international roster of experts on malignant pleural mesothelioma ... Santa Monica, Calif. , to discuss their latest ... rare form of cancer that results from exposure to ... the chest. Hosted by UCLA and the ... International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma ...
(Date:5/24/2013)... Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider ... Robert Grieve , the Company,s chairman and ... executive vice president and chief financial officer, will present at ... May 30, 2013 in New York City ... Company,s presentation is scheduled to begin at 1:30 p.m. EDT. ...
(Date:5/24/2013)... BEIJING , May 24, 2013 China ... "Company"), a leading fully integrated plasma-based biopharmaceutical company in ... Company has recently learned from a public announcement issued ... a public company listed on Shenzhen Stock Exchange, that ... Chan ("Ms. Chan"), one of the shareholders ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4
... Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: ... focusing on the development, manufacturing, marketing and selling of ... it plans to release its fourth quarter and full ... March 25, 2011. Tongjitang,s management team will ...
... MADISON, N.J., March 21, 2011 Quest Diagnostics ... provider of diagnostic testing, information and services, announced ... aggregate principal amount of four series of senior ... shelf registration statement filed with the Securities and ...
Cached Medicine Technology:Tongjitang Chinese Medicines Company to Announce Fourth Quarter and Full Year 2010 Financial Results 2Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering 2
... early 1990s, the "Reversed" shoulder prosthesis has ... great success. More recently, an ever-growing number ... begun to champion this prosthesis and the ... This reversed technology is the result of ...
... spectrofluorometer is the ... among the FLUORAT®-02 ... intended for scientific ... and for operation ...
... The Gemini XPS spectrofluorometer ... measurements as required by ... assays. Cellular and molecular ... drug screening, and SNP ...
The FluoroMax-3 is the entry level spectrofluorometer from Spex®, yet offers features not found in most of the top models of the competition....
Medicine Products: